How Sweet Syndrome is Diagnosed
At a Glance
Sweet syndrome is diagnosed by combining sudden painful skin lesions with a biopsy showing a large buildup of neutrophils in the skin, without primary blood vessel inflammation, plus findings such as fever, abnormal blood tests, a related condition, or rapid steroid response.
Confirming a diagnosis of Sweet syndrome is a precise process that combines what your doctor sees on your skin with what a pathologist sees under a microscope. Because the condition so closely mimics severe infections, doctors use a specific set of “Major” and “Minor” criteria as a commonly used framework to support an accurate diagnosis [1].
The Diagnostic Framework
To support a diagnosis of classic Sweet syndrome, this framework suggests you must meet both of the Major criteria and at least two of the Minor criteria listed below [1]. This is a guide, not an inflexible rule, and clinical judgment is required.
Major Criteria (Both Required)
- Abrupt Onset: You suddenly develop painful, raised, red or plum-colored plaques or nodules [1].
- Specific Biopsy Findings: A skin biopsy shows a “dense neutrophilic infiltrate”—a massive collection of white blood cells—deep in the skin without primary evidence of true blood vessel inflammation (vasculitis) [1][2].
Minor Criteria (At Least Two Required)
- Fever: A temperature higher than 100.4°F (38°C) [1].
- Trigger or Association: A recent infection (like a sore throat), pregnancy, an underlying inflammatory condition, or an associated malignancy [1].
- Rapid Treatment Response: Your skin and fever improve significantly within days of starting systemic steroids or potassium iodide [1][3].
- Abnormal Blood Tests: At least three of the following four results are present [1]:
- ESR (Sed Rate): Greater than 20 mm/h.
- CRP (C-Reactive Protein): A “positive” or elevated result.
- White Blood Cell Count: Greater than 8,000 per microliter.
- Neutrophil Percentage: More than 70% of your white blood cells are neutrophils.
Why the Biopsy is Essential
The skin punch biopsy is an important tool for diagnosing Sweet syndrome. During this procedure, a small, cylinder-shaped piece of skin is removed for testing [4].
Ideally, it is critical that this biopsy is performed before you start taking steroid medications like prednisone when it is clinically safe to do so [4]. Steroids work so quickly that they can “clear out” the neutrophils from your skin within hours, potentially leading to a normal-looking biopsy that hides the true diagnosis [3]. However, life-saving treatment for suspected sepsis or necrotizing infection always takes priority; a biopsy obtained after treatment may still provide useful information. Additionally, the biopsy allows the lab to perform cultures to help evaluate if bacteria, fungi, or viruses are causing the eruption [4]. While negative stains or cultures do not perfectly guarantee sterility, they strongly support the diagnosis.
Reading Your Pathology Report
When you receive your pathology report, it may contain complex medical jargon. Use this checklist to audit the findings with your doctor:
| Feature | What it Means | Why it Matters |
|---|---|---|
| Dense Neutrophilic Infiltrate | A thick “swarm” of neutrophils (white blood cells) in the dermis layer [2]. | This is the hallmark of Sweet syndrome [1]. |
| Dermal Edema | Swelling or fluid buildup in the deeper layers of the skin [5]. | Explains why the lesions look “juicy” or raised [6]. |
| No Primary Leukocytoclastic Vasculitis | No primary evidence that the small blood vessels are being destroyed [1]. | Helps rule out other autoimmune conditions, though secondary vessel inflammation can occur [7]. |
| Negative Cultures/Stains | Tests for bacteria (Gram stain) and fungi (PAS stain) show no germs [4]. | Helps confirm the inflammation is “sterile” and not a primary infection [2]. |
In some cases, the report may mention leukocytoclasia—which is simply the “dust” or debris left behind by broken-down neutrophils [8]. While it sounds similar to vasculitis, finding this debris is common in Sweet syndrome and does not necessarily mean your blood vessels are the primary target [8]. If your report mentions “histiocytoid” cells or involvement of the fat layer (subcutaneous), your doctor may need to look for specific variants of the disease [9][10].
Common questions in this guide
What tests do doctors use to confirm Sweet syndrome?
What will my skin biopsy show if I have Sweet syndrome?
Why does the timing of steroids matter before a Sweet syndrome biopsy?
Which blood test results can support a Sweet syndrome diagnosis?
Do negative cultures and stains rule out an infection?
What does leukocytoclasia on a Sweet syndrome pathology report mean?
Get notified when new evidence is published on Sweet syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
[Classical Sweet syndrome with multiple organ lesions by 18F-FDG PET/CT: A case report].
Chen Z, Qiu Y, Kang L
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2025; (57(2)):403-407.
PMID: 40219578 - 2
New Practical Aspects of Sweet Syndrome.
Joshi TP, Friske SK, Hsiou DA, Duvic M
American journal of clinical dermatology 2022; (23(3)):301-318 doi:10.1007/s40257-022-00673-4.
PMID: 35157247 - 3
Periorbital Necrotizing Sweet Syndrome: A Case Report and Literature Review.
Bair H, Murdock N, Cheslow L, et al.
Ophthalmic plastic and reconstructive surgery 2026; (42(5)):e226-e231 doi:10.1097/IOP.0000000000003171.
PMID: 41474121 - 4
Sweet's syndrome in a patient with chronic lymphocytic leukaemia.
Smith CR, Williams P
BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-220317.
PMID: 28784883 - 5
Lymphocytes in Sweet syndrome: A potential diagnostic pitfall.
Kazlouskaya V, Junkins-Hopkins JM
Journal of cutaneous pathology 2018; (45(3)):217-222 doi:10.1111/cup.13096.
PMID: 29265393 - 6
Recurrent Idiopathic Sweet Syndrome - Case Report and Literature Review.
PĂtraŞcu V, Geoloaica LG, Ciurea RN
Current health sciences journal 2020; (46(1)):90-98 doi:10.12865/CHSJ.46.01.12.
PMID: 32637170 - 7
Sweet Syndrome With Vasculitis: Time To Adopt a New Criteria?
Shakir MH, Basit SA, Zaidi SMH, et al.
Cureus 2023; (15(11)):e48399 doi:10.7759/cureus.48399.
PMID: 38074061 - 8
Atypical Presentation of Sweet's Syndrome: A Case Report and Review of the Literature.
Smoljan Filipović D, Mokos M, Franin I, Bulat V
Acta dermatovenerologica Croatica : ADC 2025; (33(4)):168-173.
PMID: 42370655 - 9
Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome.
Alegría-Landa V, Rodríguez-Pinilla SM, Santos-Briz A, et al.
JAMA dermatology 2017; (153(7)):651-659 doi:10.1001/jamadermatol.2016.6092.
PMID: 28296991 - 10
Subcutaneous Sweet Syndrome Presenting as Cellulitis in a Pregnant Female.
Turner M, Chauhan K
Cureus 2021; (13(9)):e17999 doi:10.7759/cureus.17999.
PMID: 34667675
This page explains Sweet syndrome diagnostic criteria, biopsy findings, and blood tests for informational purposes only; it does not constitute medical advice. Your dermatologist and pathologist can interpret your results and guide urgent care decisions.